<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331874</url>
  </required_header>
  <id_info>
    <org_study_id>206698(59-03-16)</org_study_id>
    <nct_id>NCT03331874</nct_id>
  </id_info>
  <brief_title>RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma</brief_title>
  <acronym>RCM-1</acronym>
  <official_title>Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Julie Dawson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norfolk and Norwich University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Basal cell carcinoma (BCC) is the commonest non melanoma skin cancer in the UK and its
      incidence is rising. The Norfolk and Norwich University Hospital Foundation Trust (NNUHFT)
      see and excise approximately 3,000 new cases of BCC each year. Many of these patients have a
      biopsy to confirm their diagnosis before being listed for surgical excision. In vivo
      reflectance confocal microscopy (RCM) involves using a machine which can examine the upper
      layers of the skin non invasively.

      In clinically suspicious lesions, the Investigators will use RCM prior to biopsy with the aim
      of demonstrating that RCM can accurately diagnose BCC. The aim of this study is to determine
      the feasibility and utility of using RCM for the diagnosis of BCC in the NHS setting, thereby
      shortening the patient pathway and effectively using limited public resources. If the
      Investigators' study shows that RCM can accurately diagnose BCC in these patients then this
      would prevent the need for biopsy as a routine in these patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited from the outpatient clinics of the Departments of Dermatology and
      Plastic Surgery at the Norfolk and Norwich University Hospital Foundation Trust. These will
      be patients who have been assessed in clinic by a consultant dermatologist or consultant
      plastic surgeon. They will be suspected of having a BCC on the head and neck region. Clinical
      and dermoscopic (a dermatoscope is a hand held microscope) images will be taken by the
      Medical Illustration at NNUHFT as part of their routine standard of care. Patients will be
      invited to participate in the trial and provided with a patient information leaflet. They
      will be given sufficient time to review the information sheet and ask questions. Patients
      will be consented to having reflectance confocal microscopy performed of the target lesion
      before undergoing biopsy for histology. These patients would be having photographs, including
      dermoscopic images, and a biopsy as part of their standard of care prior to their final
      treatment being determined - the only additional intervention is examination with the
      confocal microscope.

      The images taken of the tumour by the reflectance confocal microscope will be anonymised.
      These images will then be examined by a different in house dermatologist who has undergone
      training in examining confocal images. The images will also be sent to a dermatologist in
      Modena, Italy who is experienced in interpreting confocal microscopic images - both of these
      dermatologists will be blinded as to the patient's history and the results of the punch
      biopsy.

      The biopsies will undergo routine processing in our histopathology laboratory as normal and
      will be analysed by a pathologist who will be unaware of the findings on confocal microscopy.

      The patients will undergo one additional intervention over-and-above their standard
      investigation and treatment pathway. The treatment pathway for the patients will not be
      lengthened or shortened by their participation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2017</start_date>
  <completion_date type="Anticipated">February 5, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 5, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity &amp; Sensitivity of RCM in diagnosing BCC compared to standard histology</measure>
    <time_frame>18 months</time_frame>
    <description>Specificity &amp; Sensitivity of RCM in diagnosing BCC compared to standard histology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inter- &amp; intra-observer agreement in assessing RCM images</measure>
    <time_frame>18 months</time_frame>
    <description>Inter- &amp; intra-observer agreement in assessing RCM images</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">345</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Basal Cell Carcinoma</arm_group_label>
    <description>Diagnosis of Basal Cell Carcinoma by Reflectance confocal microscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Reflectance Confocal Microscopy</intervention_name>
    <description>In-vivo microscope</description>
    <arm_group_label>Basal Cell Carcinoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        See Above
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients 18 years or older with a suspected diagnosis of BCC of the
        head and neck region.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Garioch, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant Oncologist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Garioch, Dr</last_name>
    <phone>+44 01603 288210</phone>
    <email>jennifer.garioch@nnuh.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Moncrieff, Professor</last_name>
    <phone>+44 01603 288126</phone>
    <email>marc.moncrieff@nnuh.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Norfolk &amp; Norwich University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Dawson, Mrs</last_name>
      <phone>+44 1603 286611</phone>
      <email>julie.dawson@nnuh.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol. 2013 Jun;38(4):367-9. doi: 10.1111/ced.12016. Epub 2013 Mar 18.</citation>
    <PMID>23496262</PMID>
  </reference>
  <reference>
    <citation>Sauermann K, Gambichler T, Wilmert M, Rotterdam S, Stücker M, Altmeyer P, Hoffmann K. Investigation of basal cell carcinoma [correction of carcionoma] by confocal laser scanning microscopy in vivo. Skin Res Technol. 2002 Aug;8(3):141-7.</citation>
    <PMID>12236882</PMID>
  </reference>
  <reference>
    <citation>González S, Tannous Z. Real-time, in vivo confocal reflectance microscopy of basal cell carcinoma. J Am Acad Dermatol. 2002 Dec;47(6):869-74.</citation>
    <PMID>12451371</PMID>
  </reference>
  <reference>
    <citation>Goldgeier M, Fox CA, Zavislan JM, Harris D, Gonzalez S. Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma. Dermatol Surg. 2003 Mar;29(3):205-10.</citation>
    <PMID>12614409</PMID>
  </reference>
  <reference>
    <citation>Marra DE, Torres A, Schanbacher CF, Gonzalez S. Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol Surg. 2005 May;31(5):538-41.</citation>
    <PMID>15962737</PMID>
  </reference>
  <reference>
    <citation>Nori S, Rius-Díaz F, Cuevas J, Goldgeier M, Jaen P, Torres A, González S. Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol. 2004 Dec;51(6):923-30.</citation>
    <PMID>15583584</PMID>
  </reference>
  <reference>
    <citation>Longo C, Farnetani F, Ciardo S, Cesinaro AM, Moscarella E, Ponti G, Zalaudek I, Argenziano G, Pellacani G. Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases. Br J Dermatol. 2013 Jul;169(1):58-67. doi: 10.1111/bjd.12259.</citation>
    <PMID>23374159</PMID>
  </reference>
  <reference>
    <citation>Gerger A, Koller S, Weger W, Richtig E, Kerl H, Samonigg H, Krippl P, Smolle J. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer. 2006 Jul 1;107(1):193-200.</citation>
    <PMID>16615102</PMID>
  </reference>
  <reference>
    <citation>Eichert S, Möhrle M, Breuninger H, Röcken M, Garbe C, Bauer J. Diagnosis of cutaneous tumors with in vivo confocal laser scanning microscopy. J Dtsch Dermatol Ges. 2010 Jun;8(6):400-10. doi: 10.1111/j.1610-0387.2010.07333.x. Epub 2010 Feb 5. Review. English, German.</citation>
    <PMID>20141551</PMID>
  </reference>
  <reference>
    <citation>Guitera P, Menzies SW, Longo C, Cesinaro AM, Scolyer RA, Pellacani G. In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases. J Invest Dermatol. 2012 Oct;132(10):2386-2394. doi: 10.1038/jid.2012.172. Epub 2012 Jun 21.</citation>
    <PMID>22718115</PMID>
  </reference>
  <reference>
    <citation>Peppelman M, Wolberink EA, Blokx WA, van de Kerkhof PC, van Erp PE, Gerritsen MJ. In vivo diagnosis of basal cell carcinoma subtype by reflectance confocal microscopy. Dermatology. 2013;227(3):255-62. doi: 10.1159/000354762. Epub 2013 Oct 18.</citation>
    <PMID>24158236</PMID>
  </reference>
  <reference>
    <citation>Castro RP, Stephens A, Fraga-Braghiroli NA, Oliviero MC, Rezze GG, Rabinovitz H, Scope A. Accuracy of in vivo confocal microscopy for diagnosis of basal cell carcinoma: a comparative study between handheld and wide-probe confocal imaging. J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1164-9. doi: 10.1111/jdv.12780. Epub 2014 Oct 22.</citation>
    <PMID>25338750</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2017</study_first_submitted>
  <study_first_submitted_qc>November 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Norfolk and Norwich University Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Julie Dawson</investigator_full_name>
    <investigator_title>Acting Research Services Manager</investigator_title>
  </responsible_party>
  <keyword>confocal</keyword>
  <keyword>basal</keyword>
  <keyword>carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

